Want to see PRE full AI Analyst Report?
PRE Stock Chart & Stats
$18.74
-$0.68(-3.50%)
At close: 4:00 PM EDT
$18.74
-$0.68(-3.50%)
Day’s Range― - ―
52-Week Range$7.18 - $23.63
Previous Close$18.74
Volume149.20K
Average Volume (3M)216.11K
Market Cap
$325.90M
Enterprise Value$222.43
Total Cash (Recent Filing)$106.03M
Total Debt (Recent Filing)$457.00K
Price to Earnings (P/E)―
Beta0.04
Next Earnings
Aug 18, 2026EPS Estimate
-0.84Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-4.58
Shares Outstanding15,562,491
10 Day Avg. Volume398,992
30 Day Avg. Volume216,110
Financial Highlights & Ratios
PEG Ratio0.22
Price to Book (P/B)1.27
Price to Sales (P/S)2.40
P/FCF Ratio-10.05
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price Target
$37.00Price Target Upside97.44% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
EPS Forecast (FY)-3.26
Revenue Forecast (FY)$218.08M
Bulls Say, Bears Say
Bulls Say
Accelerating Revenue And Improving Gross MarginsSustained, outsized top-line growth alongside material gross margin expansion signals scalable demand and improved unit economics. These durable improvements reflect product-market fit and manufacturing/fulfillment scale that can support margin recovery as SG&A normalizes over the next several quarters.
High Subscription Mix And Improving LTVA subscription-first model with high attachment and growing cohorts increases recurring revenue visibility and raises customer lifetime value. Strong cohort acceleration and rising AOV imply durable customer economics, improving predictability of revenue and enabling marketing spend to be evaluated against longer-term payback.
Access To Large Non-dilutive Growth FinancingA sizeable non-dilutive facility tied to cohort revenue provides durable capital to scale customer acquisition without equity dilution or typical bank covenants. This structure aligns funding with unit economics and materially increases capacity to scale marketing while preserving balance-sheet flexibility.
Bears Say
Persistent Losses And Negative Cash FlowMulti-year operating losses and negative free cash flow create structural funding risk: the business must either materially improve FCF conversion or rely on external capital to sustain growth. Ongoing negative margins constrain reinvestment capacity and raise execution risk until profitable cohorts scale further.
High Marketing-driven Cash BurnDeliberate, elevated marketing investment accelerates scale but also intensifies cash depletion and operating losses. If unit economics or channel performance soften, sustained high spend can shorten runway and force either higher-cost financing or cutbacks that would slow subscriber growth and long-term margin improvement.
Customer Acquisition Concentration (Meta Reliance)Heavy reliance on a single ad platform concentrates regulatory, cost and algorithmic risk: policy shifts or rising CPMs on Meta could harm growth and CAC. Early-stage diversification means the company lacks proven alternative channels to sustain scaled growth should Meta performance deteriorate.
Prenetics Group News
PRE FAQ
What was Prenetics Group Limited’s price range in the past 12 months?
Prenetics Group Limited lowest stock price was $7.17 and its highest was $23.63 in the past 12 months.
What is Prenetics Group Limited’s market cap?
Prenetics Group Limited’s market cap is $325.90M.
When is Prenetics Group Limited’s upcoming earnings report date?
Prenetics Group Limited’s upcoming earnings report date is Aug 18, 2026 which is in 5 days.
How were Prenetics Group Limited’s earnings last quarter?
Prenetics Group Limited released its earnings results on May 14, 2026. The company reported -$1.36 earnings per share for the quarter, missing the consensus estimate of -$1.017 by -$0.343.
Is Prenetics Group Limited overvalued?
According to Wall Street analysts Prenetics Group Limited’s price is currently Undervalued.
Does Prenetics Group Limited pay dividends?
Prenetics Group Limited pays a Quarterly dividend of $0.7 which represents an annual dividend yield of N/A. See more information on Prenetics Group Limited dividends here
What is Prenetics Group Limited’s EPS estimate?
Prenetics Group Limited’s EPS estimate is -0.84.
How many shares outstanding does Prenetics Group Limited have?
Prenetics Group Limited has 15,562,491 shares outstanding.
What happened to Prenetics Group Limited’s price movement after its last earnings report?
Prenetics Group Limited reported an EPS of -$1.36 in its last earnings report, missing expectations of -$1.017. Following the earnings report the stock price went up 0.114%.
Which hedge fund is a major shareholder of Prenetics Group Limited?
Currently, no hedge funds are holding shares in PRE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Prenetics Group Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$37.00 (97.44% Upside)
$37.00 (97.44% Upside)
Blogger Sentiment
Bullish
PRE Sentiment 100%
Sector Average ―
Sector Average ―
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.3%
Last 30 Days ▼ 8.5%
Last 30 Days ▼ 8.5%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
134.86%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-14.07%
Trailing 12-Months
Company Description
Prenetics Group Limited
Prenetics Group Limited (Nasdaq: PRE) is a healthcare and life sciences company focused on diagnostics and genomic testing. The company provides products and services in areas such as genetic testing, disease screening, and related laboratory diagnostics, serving consumers and enterprise/clinical customers through its testing platforms and lab capabilities.
PRE Company Deck
PRE Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presented a strongly positive operational narrative: very high revenue growth, significant improvement in gross margins, rapid cohort/LTV acceleration, healthy subscriber growth and consumption, raised guidance, and substantial cash resources after a Bitcoin sale. Management acknowledged near-term EBITDA losses driven by deliberate marketing investments to scale international quarterly subscriptions and noted preliminary accounting items pending close. Execution risks remain around channel diversification, potential reporting clarity, and delivering new product launches. On balance the positive growth, improving unit economics, and strong cohort metrics outweigh the near-term losses and execution items.View all PRE earnings summariesPRE Stock 12 Month Forecast
Average Price Target
$37.00
▲(97.44% Upside)
Technical Analysis
Ownership Overview
0.70% Insiders
0.04% Mutual Funds
0.18% Other Institutional Investors
99.08% Public Companies and
Individual Investors